Striving for Chemical, Biological & Radiation Safety, Leadership Buy-In & Sustainable Waste Management
Returning to Boston in 2026, the 3rd Annual EHS in Biopharma Summit is the only industry-specific meeting on the East Coast dedicated to uniting Global, Corporate, Vice President and Director-level Environment, Health & Safety leaders across biotech, pharma, CROs and CDMOs.
As the biopharma industry continues its rapid expansion, driven by the rise of radiopharmaceuticals, antibody-drug conjugates, cell and gene therapies, and novel vaccines, EHS professionals are under mounting pressure to scale safety systems, mitigate new biological and chemical risks, and embed sustainability into operations. This year’s meeting provides the strategic foresight and technical depth needed to support this transformation, ensuring zero serious injuries and fatalities in increasingly complex R&D and manufacturing settings.
Join 100+ senior EHS decision-makers from Sanofi, AbbVie, Biogen, AstraZeneca, Charles River Laboratories, Novartis, Jackson Laboratories, Ultragenyx, Genentech, and more to connect, collaborate, and benchmark your strategies against industry leaders tackling the same challenges.
The content was highly useful, especially those sessions focused on safety culture/behavior and leadership engagement. What stood out was the common challenges that our industry is navigating through.
Grace Rosario, Director, Safety, Health & Environment, AstraZeneca
Great info sharing with peers in industry. The variety of company sizes present is also important. Being at a conference with EHS folks from big pharma and small biotech was eye opening.
Ronald Amoling, Associate Director Environment, Health & Safety, Bristol Myers Squibb
It was great to get peers together to discuss the key issues facing the industry and profession, and hearing strategies/approaches each are taking to address these issues. The agenda was well planned, and the venue was very convenient.
Victor D’Amato, Head of Safety, Health & Environment, Global Operations, AstraZeneca
What Makes this Summit Unique
Built for Biopharma
The only event exclusively focused on EHS within drug development, connecting experts managing risk across R&D and manufacturing environments.
Strategic and Technical Depth
A balanced agenda for VPs and Global Heads shaping long-term EHS strategy and Directors and Specialists driving implementation and innovation.
Timely & Transformative
As new drug modalities reshape facility design, safety standards, and environmental priorities, this summit empowers EHS leaders to de-risk innovation and enable sustainable growth.
Explore the Full Event Guide
- 25+ World Class Speakers with Unique Insights
- 100+ Industry Attendees from Across the EHS Landscape
- 4 Deep Dive Workshops
- 3 Data Driven AI Presentations
- 8+ Hours of Face-to-Face Networking Opportunities
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Dive into the only agenda built by and for EHS leaders in biopharma. Gain practical takeaways from real-world case studies spanning R&D labs to large-scale manufacturing, and join interactive roundtables and workshops tackling today’s toughest challenges - from high-potency containment and AI-driven compliance to sustainable facility design and zero-harm culture.
Partner With Us
Stand alongside the most trusted EHS innovators in biopharma. Position your solutions where buying decisions happen - in front of global, corporate, and site-level leaders actively seeking new technologies, systems, and partners to drive safer, smarter, and more compliant operations.
Join Industry Experts
Connect directly with senior Environment, Health & Safety professionals shaping the future of biopharma. Exchange ideas with peers from top pharma, biotech, CRO and CDMO organisations, and build powerful collaborations during structured networking sessions designed to foster real partnerships and actionable insights.